Delivery Order SPE2DR25D3002-SPE2DR26FVYG7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,923.60 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL formulation. The contract, which carries a firm fixed price structure with no set-aside designation, was competitively awarded on November 20, 2025, with an ultimate completion date of November 21, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $20,171.71 delivery order to AmerisourceBergen Drug Corp for Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL format, with an ultimate completion date of December 8, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $4,004.52 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials. This competitively awarded, firm fixed-price contract was issued on December 2, 2025, with an ultimate completion date of December 3, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $17,890.25 delivery order to AmerisourceBergen Drug Corp for supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL formulations. This competitively awarded, firm fixed-price delivery order is set to be completed by November 14, 2025, and represents fulfillment under AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL vials, with a ceiling value of $4,554.14. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 10, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,455.97 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL vials. This is a firm fixed price, non-competitive set-aside contract with an ultimate completion date of June 2, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a delivery order valued at $11,874.64 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. This competitively awarded, firm fixed-price delivery order was executed on November 3, 2025, with an ultimate completion date of November 4, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract includes no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order valued at $2,621.17 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml quantities. This competitively awarded, firm fixed-price delivery order is set to be completed by August 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $35,602.74 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL format. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of August 14, 2025. The delivery order was issued on August 13, 2025, as a child contract under AmerisourceBergen's larger pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,633.89 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. This firm fixed-price, competitively awarded contract—with no set-aside designation—is scheduled for completion by January 14, 2026, just one day after the award date of January 13, 2026. The work is being performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania....
- SPE2DR25D3002Indefinite Delivery Contract
- SPE2DR25D3002-SPE2DR26FVYG7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,027.03 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 ml vials, with a completion date of January 13, 2026. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on a full and open basis. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate operations as a critical vendor for federal medical procurement. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s (doing business as AmerisourceBergen) larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion contract vehicle valued through December 2031 that serves as the primary procurement mechanism for comprehensive pharmaceutical and medical supply support to military healthcare programs worldwide. The contract covers specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, enabling the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems to access essential medications including diabetes treatments like Ozempic through a flexible, indefinite quantity contracting structure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 1/11/26 |